Microbix offers dengue antigen for diagnostic use:
This article was originally published in Clinica
Executive Summary
Microbix of Toronto, Canada, which has developed an antigen to dengue 2 in co-operation with the US Department of Defense's Walter Read Army Institute of Research dengue vaccine programme, is making it available for test manufacturers. According to the company, the sucrose-purified antigen can be incorporated into a variety of tests, including ELISA and rapid tests. Dengue fever is a mosquito-vectored disease which kills 15% of the 50 million who get it each year.